RxDoctor Payments Data

Corey Groh

Podiatrist · Indianapolis, INNPI 1386909349

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,750 of the $56,548 with a category attached, or 72.1%. Extremity Medical accounts for 87.2% of it on its own, with 18 other manufacturers making up the rest. Among podiatrist clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,548in general payments, 2019–2025

Across 100 payments — averaging $565.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Extremity Medical$49K
  • Stryker$3K
  • Crossroads Orthopedics, LLC$3K
  • Johnson & Johnson$447
  • Integra Lifesciences Corporation$382
  • Boston Scientific$171
  • plus $900 from 13 others

What the payments were for

  • Royalty or licence$6,92612%
  • Consulting fees$40,75072%
  • Travel & lodging$2,9175%
  • Food & beverage$2,9925%
  • Education$2,9155%
  • Other$480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,548 in reported general payments places this provider in the 95th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$95,035
Medicare patients
355
Services billed
1,564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate50$636
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen83$606
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen75$576
Ciclopirox24$546
Naloxone Hcl11$501
Clotrimazole13$492
Diclofenac Sodium27$482
Terbinafine Hcl24$447
Ammonium Lactate36$297
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$253
Imiquimod11$191
Gabapentin20$174
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$139
Methylprednisolone18$138
Pregabalin19$121

Paid to pharmacies, not to this prescriber.

Other podiatrist in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →